NCOUNTER SPRINT
LIVE

Serial Number

86357017

Owner

NanoString Technologies, Inc.

Attorney

Alyssa M. Worsham

Filing Date

Aug 4, 2014

Add to watchlist:

No watchlists yet
View on USPTO

NCOUNTER SPRINT Trademark

Serial Number: 86357017 • Registration: 5124745

NCOUNTER SPRINT is a trademark filed by NanoString Technologies, Inc. on August 4, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

NanoString Technologies, Inc. (31 trademarks)

530 Fairview Avenue North, Suite 2000
Seattle, WA 98109

Entity Type: 03

BRUKER SPATIAL BIOLOGY, INC. (22 trademarks)

40 MANNING ROAD
BILLERICA, MA 01821

Entity Type: 03

Trademark Details

Filing Date

August 4, 2014

Registration Date

January 17, 2017

Published for Opposition

September 22, 2015

Goods & Services

diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors, namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing

diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care, namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes

computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples, detecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications, all being downloadable

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 9, 2026 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 9, 2026 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 9, 2026 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 9, 2026 APRE
TEAS SECTION 8 & 9 RECEIVED
Jan 29, 2026 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 17, 2026 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 4, 2024 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 29, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 29, 2022 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 29, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 25, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 17, 2022 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 18, 2020 ASCK
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 13, 2016 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 12, 2016 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2016 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Nov 17, 2016 SUPC
SOU EXTENSION 2 GRANTED
Nov 17, 2016 EX2G
USE AMENDMENT FILED
Nov 7, 2016 IUAF
SOU EXTENSION 2 FILED
Nov 7, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 7, 2016 EEXT
TEAS STATEMENT OF USE RECEIVED
Nov 7, 2016 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2016 EXRA
SOU EXTENSION 1 GRANTED
Jun 9, 2016 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 9, 2016 AITU
SOU EXTENSION 1 FILED
May 13, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
May 13, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 17, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 22, 2015 NPUB
PUBLISHED FOR OPPOSITION
Sep 22, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 19, 2015 PREV
ASSIGNED TO LIE
Aug 12, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2015 CNSA
NOTICE OF REVIVAL - E-MAILED
Jul 12, 2015 NREV
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2015 TROA
PETITION TO REVIVE-GRANTED
Jul 10, 2015 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 10, 2015 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 22, 2015 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 22, 2015 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 24, 2014 GNRN
NON-FINAL ACTION E-MAILED
Nov 24, 2014 GNRT
NON-FINAL ACTION WRITTEN
Nov 24, 2014 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2014 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Aug 14, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 13, 2014 NWOS
NEW APPLICATION ENTERED
Aug 7, 2014 NWAP